John Roxborough, MD , our team is highly experienced in administering GLP-1 treatments
If you suspect that you or someone you know has overdosed on Ozempic, seek medical attention immediately
A further dimension emerged in May 2026, when the ATTAIN-MAINTAIN trial, published in Nature Medicine , found that patients who switched to orforglipron after achieving substantial weight loss on injectable GLP-1s maintained approximately 7580% of that weight reduction
At the same time, oral small-molecule GLP-1 agonists (e.g., Lillys #orforglipron) are emerging as next-generation competitors, engineered to bypass peptide stability and absorption constraints entirely
During my search for other options, I happened upon New Jersey's Medical Weight Loss for Life...what a GAME CHANGER